The device is meant for skeletally mature patients who have had six months of non-operative treatment. It can be used at one level or two contiguous levels for degenerative disc disease with up to Grade I spondylolisthesis.
The implants can also be used to replace a vertebral body that has been resected or excised due to tumor or trauma fracture.
Read the DiFUSE release on the Xiphos line.
Read other coverage on spine devices:
– Medtronic Launches KYPHON Express Curette
– K2M Launches Lateral Access Spinal System
– Integra LifeSciences Receives FDA Clearance for ALIF Device
